Skinvisible Inc (SKVI) 0.0400 $SKVI
Global Anti-Aging Product Market 2014-2018 - Skincare Products, Cosmeceuticals, and Hair Care Products
M2 - Wed Jul 16, 8:55AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7slrvw/global_antiaging) has announced the addition of the "Global Anti-Aging Product Market 2014-2018" report to their offering. The Global Anti-aging Product market will grow at a CAGR of 6.77 percent over the period 2013-2018. Aging is associated with numerous common health problems. Anti-aging products help in fighting the various signs of aging or problems such as wrinkles, blemishes, dry lines, fine color, pores, graying, thinning, and sagging. To overcome these aging problems related to skin and hair consumers use many products that basically fall under three categories: skincare, cosmeceuticals, and hair care. The Global Anti-aging Product market can be divided into three segments: Skincare Products, Cosmeceuticals, and Hair Care Products. These are the product categories used by consumers to reduce various signs of aging and maintain youthfulness. The report, the Global Anti-aging Product Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Anti-aging Product market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Key Vendors - Beiersdorf AG - L'Or?al SA - Phosphagenics Ltd. - Procter & Gamble Co. - Unilever Group Other Prominent Vendors - Allergan Inc. - Amexdrug Corp. - Avon Products Inc. - Chanel SA - Christian Dior SA - Clarins USA Inc. - DS Healthcare Group Inc. - Elizabeth Arden Inc. - Ella Bach? - Est?e Lauder Co. Inc. - Henkel AG & Co KGaA - Jan Marini Skin Research Inc. - Johnson & Johnson Co. - Kao Corp. - NeoStrata Co. - NuSKin Enterprises - Orlane SA - Revlon Inc. - Robanda International Inc. - Shiseido Co. - SkinMedica Inc. - Skinvisible Inc. - Woodridge Labs Inc. Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Demographic Segmentation - Market Segmentation by Product - Geographical Segmentation - Key Leading Countries - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/7s..._antiaging
REV: 33.54 (+0.90), AVP: 11.14 (-0.05), RDEN: 16.21 (+0.40), DSKX: 0.94 (-0.02), AGN: 182.60 (+0.27), JNJ: 104.79 (+0.72), PG: 86.47 (+0.52)
Skinvisible's Sunscreen Meets New FDA Guidelines for Broad Spectrum and 80 Minute Water-Resistant Claims
Marketwire - Tue Mar 25, 8:06AM CDT
Skinvisible Pharmaceuticals, Inc. (OTCBB: SKVI) (OTCQB: SKVI) is pleased to announce that it has successfully completed independent testing to validate its broad spectrum sunscreen claims according to new labeling guidelines by the Food and Drug Administration (FDA) which are designed to help reduce the incidents of skin cancer in the U.S.
OTC Signal Daily Stock Watch - Skinvisible Pharmaceuticals (OTCQB: SKVI)
WorldStockWire - Mon Sep 09, 1:45AM CDT
OTC Signal tracks stocks daily and is pleased to offer its stock alerts. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Signal at the following: http://www.otcsignal.com
Skinvisible Adds Additional Patent Protection to Its Topical Drug Delivery Technology
Marketwire - Wed Jun 26, 8:05AM CDT
Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI) today announced that it has expanded its US patent protection for Invisicare(R), its unique topical drug delivery technology. Skinvisible has been granted US Patent Number 8,481,058 for the topical composition precursor for Invisicare with an expiry date of June 28, 2021. The patent issued by the United States Patent and Trademark Office (USPTO) is a division of Skinvisible's US patent "Topical Composition, Topical Composition Precursor, and Methods for Manufacturing and Using." This new patent expands Skinvisible's patent portfolio to fourteen US and international patents and is one of a series of five patents (including Skinvisible's initial product patent) granted in the United States specifically protecting Invisicare and the products formulated with it.
Global Anti-Aging Product Market 2014-2018 - Skincare Products, Cosmeceuticals, and Hair Care Products
M2 - Wed Jul 16, 8:55AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7slrvw/global_antiaging) has announced the addition of the "Global Anti-Aging Product Market 2014-2018" report to their offering. The Global Anti-aging Product market will grow at a CAGR of 6.77 percent over the period 2013-2018. Aging is associated with numerous common health problems. Anti-aging products help in fighting the various signs of aging or problems such as wrinkles, blemishes, dry lines, fine color, pores, graying, thinning, and sagging. To overcome these aging problems related to skin and hair consumers use many products that basically fall under three categories: skincare, cosmeceuticals, and hair care. The Global Anti-aging Product market can be divided into three segments: Skincare Products, Cosmeceuticals, and Hair Care Products. These are the product categories used by consumers to reduce various signs of aging and maintain youthfulness. The report, the Global Anti-aging Product Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Anti-aging Product market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Key Vendors - Beiersdorf AG - L'Or?al SA - Phosphagenics Ltd. - Procter & Gamble Co. - Unilever Group Other Prominent Vendors - Allergan Inc. - Amexdrug Corp. - Avon Products Inc. - Chanel SA - Christian Dior SA - Clarins USA Inc. - DS Healthcare Group Inc. - Elizabeth Arden Inc. - Ella Bach? - Est?e Lauder Co. Inc. - Henkel AG & Co KGaA - Jan Marini Skin Research Inc. - Johnson & Johnson Co. - Kao Corp. - NeoStrata Co. - NuSKin Enterprises - Orlane SA - Revlon Inc. - Robanda International Inc. - Shiseido Co. - SkinMedica Inc. - Skinvisible Inc. - Woodridge Labs Inc. Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Demographic Segmentation - Market Segmentation by Product - Geographical Segmentation - Key Leading Countries - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/7s..._antiaging
REV: 33.54 (+0.90), AVP: 11.14 (-0.05), RDEN: 16.21 (+0.40), DSKX: 0.94 (-0.02), AGN: 182.60 (+0.27), JNJ: 104.79 (+0.72), PG: 86.47 (+0.52)
Skinvisible's Sunscreen Meets New FDA Guidelines for Broad Spectrum and 80 Minute Water-Resistant Claims
Marketwire - Tue Mar 25, 8:06AM CDT
Skinvisible Pharmaceuticals, Inc. (OTCBB: SKVI) (OTCQB: SKVI) is pleased to announce that it has successfully completed independent testing to validate its broad spectrum sunscreen claims according to new labeling guidelines by the Food and Drug Administration (FDA) which are designed to help reduce the incidents of skin cancer in the U.S.
OTC Signal Daily Stock Watch - Skinvisible Pharmaceuticals (OTCQB: SKVI)
WorldStockWire - Mon Sep 09, 1:45AM CDT
OTC Signal tracks stocks daily and is pleased to offer its stock alerts. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Signal at the following: http://www.otcsignal.com
Skinvisible Adds Additional Patent Protection to Its Topical Drug Delivery Technology
Marketwire - Wed Jun 26, 8:05AM CDT
Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI) today announced that it has expanded its US patent protection for Invisicare(R), its unique topical drug delivery technology. Skinvisible has been granted US Patent Number 8,481,058 for the topical composition precursor for Invisicare with an expiry date of June 28, 2021. The patent issued by the United States Patent and Trademark Office (USPTO) is a division of Skinvisible's US patent "Topical Composition, Topical Composition Precursor, and Methods for Manufacturing and Using." This new patent expands Skinvisible's patent portfolio to fourteen US and international patents and is one of a series of five patents (including Skinvisible's initial product patent) granted in the United States specifically protecting Invisicare and the products formulated with it.
